Zenith Epigenetics Corp. announced that it has appointed Dr. Norman C.W. Wong to its Board of Directors to replace Dr. Peter Johann. Dr. Wong comes to Zenith with a wealth of experience as co-founder of Resverlogix, with expertise in the fields of endocrinology and molecular biology.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 USD | +15.38% | +15.38% | +25.00% |
- Stock Market
- Equities
- ZHCLF Stock
- News Zenith Capital Corp.
- Zenith Epigenetics Corp. Announces Board Changes